Due to health issues, this site is no longer maintained and will be shut down shortly. |
ADMA Biologics Inc is a biopharmaceutical company. The Company develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases.
$3.32 -0.01 (-0.15%)
As of 03/27/2023 14:02:18 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.